Dietary starches and complex carbohydrates

Dietary starches and complex carbohydrates are the primary source of exogenous glucose, consisting of glucose polymers like amylose and amylopectin (National Institute of Diabetes and Digestive and Kidney Diseases, 2017). In the gastrointestinal lumen, these molecules are broken down by salivary and pancreatic alpha-amylase and intestinal brush-border enzymes such as alpha-glucosidase (StatPearls, 2023). This enzymatic hydrolysis is essential for the absorption of glucose into the systemic circulation. While not therapeutic targets themselves, the metabolic pathways involving these carbohydrates are modulated by drugs like alpha-glucosidase inhibitors to manage postprandial blood glucose levels in patients with type 2 diabetes (DrugBank, 2024). Slowing the digestion of these carbohydrates helps prevent rapid spikes in blood sugar, which is crucial for glycemic control. However, undigested starches reaching the colon can lead to fermentation by gut microbiota, resulting in gastrointestinal distress such as flatulence and bloating (Mayo Clinic, 2023). These carbohydrates also play a role in the management of obesity and metabolic syndrome through dietary modification. The interaction between these substrates and digestive enzymes remains a key focus of pharmacological intervention in metabolic disorders.

Other names

PolysaccharidesAmyloseAmylopectinComplex carbohydratesDigestible glycansResistant starch

Inhibition of alpha-amylase and alpha-glucosidase enzymes to delay the enzymatic hydrolysis of complex carbohydrates into absorbable monosaccharides (StatPearls, 2023).